Orexo AB (OSTO:ORX) Interest Expense : kr-54.3 Mil (TTM As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Orexo AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Orexo AB's interest expense for the three months ended in Dec. 2024 was kr -12.4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was kr-54.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Orexo AB's Operating Income for the three months ended in Dec. 2024 was kr -97.9 Mil. Orexo AB's Interest Expense for the three months ended in Dec. 2024 was kr -12.4 Mil. Orexo AB did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Orexo AB Interest Expense Historical Data

The historical data trend for Orexo AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Interest Expense Chart

Orexo AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-16.20

-28.20

-27.80

-41.20

-60.00

Orexo AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-10.60	-5.00	-21.50	-15.40	-12.40

Orexo AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-54.3 Mil.

Orexo AB (OSTO:ORX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Orexo AB's Interest Expense for the three months ended in Dec. 2024 was kr-12.4 Mil. Its Operating Income for the three months ended in Dec. 2024 was kr-97.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was kr466.0 Mil.

Orexo AB's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Orexo AB did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Orexo AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OSTO:ORX) » Definitions » Interest Expense

Traded in Other Exchanges

0H19:UK C5G:Germany

Address

Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105

Website

https://www.orexo.com

Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.

Orexo AB Headlines

No Headlines